RHY
RHYTHM BIOSCIENCES LIMITED
$0.0690
▼ -9.21%
Market cap
$24M
Turnover
$22,979
Last price
$0.0690
Day change
-9.21%
Announcements
6
Range, past year
Open 0.098 · Low 0.047 · Now 0.069 · High 0.280
Open RHY in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
RHY momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
26/100
Wyckoff phase
Downtrend6d
Trend stage
Breakdown
1 Day
-9.2%
1 Week
-11.5%
1 Month
-15.9%
1 Year
-28.9%
RSI
31
Avg daily range
5.6%
RHYTHM BIOSCIENCES LIMITED scores 26 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -34.3%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsRHY announcements
Recent price-sensitive releases.
- 2026-10-07 ColoSTAT Economic Study - Australian Public Health Savings Progress Report
- 2026-09-22 Initial ColoSTAT Assessment in UK opens new market access Progress Report
- 2026-08-27 FY26 Appendix 4E & Audited Financial Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-30 Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-04-30 Quarterly Activities Report and Appendix 4C
More Health Care stocks
Most traded in the same sector.